Analysis of the tumor-infiltrated cells revealed that compared with the administration of untreated Th9 cells, the administration of TOFA-Th9 cells resulted in significantly increased infiltration of CD45+ cells and CD8+ T cells (Fig. 6C, D). The gene discussed is PTPRC; the disease is neoplasm.